SOX2 is an epigenetic reprogramming factor and oncogene shown to regulate androgen-independent CRPC proliferation and evasion of apoptosis [57, 58] and to promote tumor metastasis by inducing EMT [59]. This evidence concerns the gene SOX2 and neoplasm.